[1]卢玲,胡跃强,廖现秋,等.加味柴胡疏肝汤君臣配伍抗癫痫作用机制的网络药理学和分子对接研究[J].西部中医药,2023,36(02):12-17.[doi:10.12174/j.issn.2096-9600.2023.02.03]
　LU Ling,HU Yueqiang,LIAO Xianqiu,et al.Research on the Mechanism of the Compatibility of Monarch and Ministerial Drug in Modified Chaihu Shugan Tang in the Treatment of Epilepsy Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2023,36(02):12-17.[doi:10.12174/j.issn.2096-9600.2023.02.03]
点击复制

加味柴胡疏肝汤君臣配伍抗癫痫作用机制的网络药理学和分子对接研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年02期
页码:
12-17
栏目:
出版日期:
2023-02-15

文章信息/Info

Title:
Research on the Mechanism of the Compatibility of Monarch and Ministerial Drug in Modified Chaihu Shugan Tang in the Treatment of Epilepsy Based on Network Pharmacology and Molecular Docking
作者:
卢玲1, 胡跃强2, 廖现秋1, 李欢1, 蔡伦2, 刁丽梅2
1.广西中医药大学，广西 南宁 530001
2.广西中医药大学第一附属医院，广西 南宁 530000
Author(s):
LU Ling1, HU Yueqiang2, LIAO Xianqiu1, LI Huan1, CAI Lun2, DIAO Limei2
1.Guangxi University of Chinese Medicine, Nanning 530001, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530000, China
关键词:
网络药理学; 分子对接技术; 癫痫; 加味柴胡疏肝汤; 君臣配伍
Keywords:
network pharmacology; molecular docking; epilepsy; modified; the compatibility of monarch and ministerial drug
分类号:
R971+.6
DOI:
10.12174/j.issn.2096-9600.2023.02.03
文献标志码:
A
摘要:
目的通过网络药理学方法探讨加味柴胡疏肝汤中君药和臣药配伍的抗癫痫作用机制，并通过分子对接技术预测药物有效成分与抗癫痫靶标的结合性。 方法从DisGeNET和GeneCards数据库中分别收集癫痫的靶标，取二者交集。在TCMSP数据库中检索加味柴胡疏肝汤中君药和臣药的有效成分及靶标。利用在线软件Venny进行映射得到加味柴胡疏肝汤君臣配伍抗癫痫作用的潜在靶标。通过STRING数据库构建基因功能关联网络。基于clusterProfiler包进行GO富集分析（gene ontology，GO）和KEGG富集分析（kyoto encyclopedia of genes and genomes，KEGG）。同时使用Cytoscape软件构建“成分-靶标-通路”关系网络。最后，通过Autodock Vina实现君臣配伍有效成分与癫痫靶标蛋白的分子对接。 结果加味柴胡疏肝汤君臣配伍的多种有效成分能够作用于癫痫的37个潜在靶标。这些潜在靶标主要影响了69个GO生物学功能。涉及了113条KEGG信号通路。此外，加味柴胡疏肝汤君臣配伍的有效成分均可与癫痫核心靶标自发地结合，且结合性良好。 结论加味柴胡疏肝汤君臣配伍的有效成分与癫痫相关的靶标具有良好的结合性。加味柴胡疏肝汤君臣配伍的有效成分可能是通过多靶标、多途径共同发挥抗癫痫作用的。
Abstract:
ObjectiveTo discuss the mechanism of the compatibility of monarch and ministerial drug in modified Chaihu Shugan Tang in treating epilepsy, and predict the binding of active ingredients to antiepileptic targets through molecular docking technology. MethodsThe targets of epilepsy were collected from DisGeNET and GeneCards databases, and their intersection was used as targets related to epilepsy. The active ingredients and the targets of monarch and ministerial drug in modified Chaihu Shugan Tang were searched from TCMSP. Online software Venny was used for mapping to obtain the potential targets of antiepileptic effects of the compatibility of monarch and ministerial drug in modified Chaihu Shugan Tang. STRING database was used to construct gene function association network, clusterProfiler pack was used to perform GO and KEGG. Meanwhile, Cytoscape software was used to build the relation network of "ingredient-targets-pathway". Consequently, Autodock Vina was used to realize molecular docking between the active ingredients of the compatibility of monarch and ministerial drug and target proteins of epilepsy. ResultsMultiple active ingredients of the compatibility of monarch and ministerial drug in modified Chaihu Shugan Tang could act on 37 potential targets of epilepsy. These potential targets mainly affect 69 GO biological function, and involve 113 KEGG signaling pathway. Besides, the active ingredients of the compatibility of monarch and ministerial drug in modified Chaihu Shugan Tang could combine with core targets of epilepsy spontaneously, presenting good combination. ConclusionActive ingredients of the compatibility of monarch and ministerial drug in modified Chaihu Shugan Tang have good combination with the epilepsy-related targets, which could possibly develop antiepileptic effects through many targets and pathways.

相似文献/References:

[1]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[2]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[3]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[4]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[5]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(02):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[6]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[7]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(02):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[8]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
　LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
[9]潘威.基于网络药理学探讨大黄治疗溃疡性结肠炎的机制[J].西部中医药,2022,35(06):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
　PAN Wei.The Mechanism of Dahuang in Treating Ulcerative Colitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(02):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
[10]李磊,宁南义,王小龙,等.基于网络药理学的新型冠状病毒肺炎核心中药靶标预测及其作用机制研究?[J].西部中医药,2021,34(11):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]
　LI Lei,NING Nanyi,WANG Xiaolong,et al.The Study on the Mechanism and Target Prediction of Core Herbs of COVID-19 Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(02):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]

备注/Memo

备注/Memo:
卢玲（1993—），女，硕士学位。研究方向：神经内科疾病的临床与基础研究。国家自然科学基金（81760809，81960858）；广西区科技厅面上项目（2017GXNSFAA198294）；广西中医药大学岐黄工程高层次人才团队培育项目（2018003）；广西卫生适宜技术研究与开发项目（s2017049）；广西中医药大学2019年研究生教育创新计划项目（YCSY20190062）。
更新日期/Last Update: 2023-02-15